Tolterodine and Speech disorder - a phase IV clinical study of FDA data

Summary:

Speech disorder is reported as a side effect among people who take Tolterodine (tolterodine tartrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lisinopril, and have High blood pressure.

The phase IV clinical study analyzes which people have Speech disorder when taking Tolterodine. It is created by eHealthMe based on reports of 8,075 people who have side effects when taking Tolterodine from the FDA, and is updated regularly.

What is Tolterodine?

Tolterodine has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 8,156 Tolterodine users. Check the latest studies of Tolterodine.

What is Speech disorder?

Speech disorder is found to be associated with 1,808 drugs and 2,279 conditions by eHealthMe. Check the latest studies of Speech disorder.

On Jul, 16, 2026

8,075 people reported to have side effects when taking Tolterodine.
Among them, 73 people (0.9%) have Speech disorder.

Could Tolterodine cause Speech disorder?

Among these 73 people:

How long have people been on Tolterodine when they have Speech disorder? *

What is the gender of people who have Speech disorder when taking Tolterodine? *

female: 60.87 %
male: 39.13 %

What is the age of people who have Speech disorder when taking Tolterodine? *

What are other drugs people take besides Tolterodine? *

What are other side effects people have besides Speech disorder? *

Nausea (feeling of having an urge to vomit): 22 people, 30.14%
Acute Kidney Failure: 19 people, 26.03%
Swallowing Difficulty: 19 people, 26.03%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 19 people, 26.03%
Mastication Disorder (disease of chewing food): 19 people, 26.03%
Nausea And Vomiting: 17 people, 23.29%
Weakness: 14 people, 19.18%
Myoglobinuria (presence of myoglobin in the urine): 13 people, 17.81%
Dizziness: 12 people, 16.44%
Hemiparesis (weakness on one side of the body): 12 people, 16.44%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 16.44%
Depression: 10 people, 13.70%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 12.33%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 7 people, 9.59%
Pain: 4 people, 5.48%
Nausea (feeling of having an urge to vomit): 3 people, 4.11%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 4.11%
Lower Respiratory Tract Infection: 3 people, 4.11%
Bladder Discomfort: 2 people, 2.74%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 2.74%

* Approximation only. Some reports may have incomplete information.

Do you take Tolterodine and have Speech disorder?

- Check whether Speech disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tolterodine:

Tolterodine (8,156 reports)

Speech disorder treatments and more:

Speech disorder (62,574 reports)

Browse all side effects of Tolterodine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Speech disorder:

Speech disorder (1,808 drugs)

Browse all the conditions that are associated with Speech disorder:

Speech disorder (2,279 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate (the active ingredients of Tolterodine) and Tolterodine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.